The study of MSC trafficking is clinically relevant for minimally invasive cell therapy to
promote regeneration of damaged tissue, to treat inflammation, and to promote …

Exposure to a variety of toxins and/or infectious agents leads to disease, degeneration and
death, often characterised by circumstances in which cells or tissues do not merely die and …

Stem cell therapies offer great promise for many diseases, especially those without current
effective treatments. It is believed that noninvasive imaging techniques, which offer the …

Nanotechnology is an area of growing public interest. Its attractiveness stems from the
promise offered socially and economically by the recent significant advances in …

Stem cell transplantation therapy has emerged as a potential treatment for ischemic stroke
and other neurodegenerative diseases. Effective delivery of exogenous cells and homing of …

Human mesenchymal stem cells (hMSC) are a promising source for cell therapy after stroke.
To deliver these cells, an IV injection appears safer than a local graft. We aimed to assess …

In the research, clinical, and wider community there is great interest in the use of stem cells
to reduce the progression, or indeed repair brain injury. Perinatal brain injury may result …

Aims Treatment of the ischemic stroke has remained a major healthcare challenge. The
phenolic compound, ferulic acid (FA), has shown promising antioxidant and neuroprotective …

Background and Purpose—Granulocyte-colony stimulating factor (G-CSF) is neuroprotective
in experimental stroke and mobilizes CD34+ peripheral blood stem cells into the circulation …

Traumatic brain injury (TBI) directly affects nearly 1.5 million new patients per year in the
USA, adding to the almost 6 million cases in patients who are permanently affected by the …